A Study to Learn About How the Flu and COVID-19 Vaccines Act in Healthy People
- Conditions
- InfluenzaCOVID-19 (Coronavirus Disease 2019)
- Interventions
- Biological: Investigational COVID-19 VaccineCombination Product: Investigational Influenza and COVID-19 Combination VaccineBiological: Licensed COVID-19 VaccineBiological: Licensed Influenza Vaccine 3Biological: Licensed Influenza Vaccine 1Biological: Licensed Influenza Vaccine 2Biological: Investigational Influenza Vaccine
- Registration Number
- NCT06821061
- Lead Sponsor
- BioNTech SE
- Brief Summary
The purpose of this study is to learn about how the flu and COVID vaccines act when given alone or when mixed together.
This study is seeking healthy participants aged 18 or older. All participants in this study will receive only 1 shot to their arm, either a flu or COVID vaccine, alone or mixed. Participants will take part in this study for about 6 months, and participants will need to visit the clinical study site at least 4 times.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 2645
Not provided
Not provided
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Arm A Investigational COVID-19 Vaccine Low Dose COVID-19 Vaccine (1a) Arm D Investigational Influenza and COVID-19 Combination Vaccine Investigational Influenza and COVID-19 Combination Vaccine (High Dose Combination 1) Arm E Investigational Influenza and COVID-19 Combination Vaccine Investigational Influenza and COVID-19 Combination Vaccine (Medium Dose Combination 2) Arm H Licensed COVID-19 Vaccine Licensed COVID-19 Vaccine Arm EE Investigational Influenza and COVID-19 Combination Vaccine Investigational Influenza and COVID-19 Combination Vaccine (High Dose Combination 3) Arm GG Licensed Influenza Vaccine 3 Licensed Influenza Vaccine (3) Arm B Investigational COVID-19 Vaccine Low Dose COVID-19 Vaccine ( 1b) Arm I Licensed Influenza Vaccine 1 Licensed Influenza Vaccine (1) Arm J Investigational Influenza and COVID-19 Combination Vaccine Investigational Influenza and COVID-19 Combination Vaccine (High Dose Combination 5) Arm C Investigational COVID-19 Vaccine Low Dose COVID-19 Vaccine ( 1c) Arm F Investigational Influenza and COVID-19 Combination Vaccine Investigational Influenza and COVID-19 Combination Vaccine (High Dose Combination 3) Arm K Investigational Influenza and COVID-19 Combination Vaccine Investigational Influenza and COVID-19 Combination Vaccine (High Dose Combination 6) Arm L Investigational Influenza and COVID-19 Combination Vaccine Investigational Influenza and COVID-19 Combination Vaccine (High Dose Combination 7) Arm AA Investigational Influenza and COVID-19 Combination Vaccine Investigational Influenza and COVID-19 Combination Vaccine (High Dose Combination 6) Arm CC Investigational Influenza and COVID-19 Combination Vaccine Investigational Influenza and COVID-19 Combination Vaccine (High Dose Combination 7) Arm FF Licensed COVID-19 Vaccine Licensed COVID-19 Vaccine Arm G Investigational Influenza and COVID-19 Combination Vaccine Investigational Influenza and COVID-19 Combination Vaccine (High Dose Combination 4) Arm M Licensed COVID-19 Vaccine Licensed COVID-19 Vaccine Arm N Licensed Influenza Vaccine 2 Licensed Influenza Vaccine (2) Arm DD Investigational Influenza and COVID-19 Combination Vaccine Investigational Influenza and COVID-19 Combination Vaccine (Medium Dose Combination 2) Arm HH Licensed Influenza Vaccine 2 Licensed Influenza Vaccine (2) Arm BB Investigational Influenza and COVID-19 Combination Vaccine Investigational Influenza and COVID-19 Combination Vaccine (High Dose Combination 4) Arm II Investigational COVID-19 Vaccine Low Dose COVID-19 Vaccine ( 1b) Arm JJ Investigational COVID-19 Vaccine Low Dose COVID-19 Vaccine ( 1c) Arm KK Investigational Influenza and COVID-19 Combination Vaccine Investigational Influenza and COVID-19 Combination Vaccine (High Dose Combination 4) Arm LL Investigational Influenza and COVID-19 Combination Vaccine Investigational Influenza and COVID-19 Combination Vaccine (High Dose Combination 7) Arm MM Investigational Influenza and COVID-19 Combination Vaccine Investigational Influenza and COVID-19 Combination Vaccine (Medium Dose Combination 2) Arm NN Investigational Influenza and COVID-19 Combination Vaccine Investigational Influenza and COVID-19 Combination Vaccine (High Dose Combination 3) Arm OO Investigational Influenza and COVID-19 Combination Vaccine Investigational Influenza and COVID-19 Combination Vaccine (High Dose Combination 5) Arm PP Investigational Influenza Vaccine Medium Dose Investigational Influenza Vaccine (1) Arm QQ Investigational Influenza Vaccine High Dose Investigational Influenza Vaccine (2) Arm RR Licensed COVID-19 Vaccine Licensed COVID-19 Vaccine Arm SS Licensed Influenza Vaccine 3 Licensed Influenza Vaccine (3)
- Primary Outcome Measures
Name Time Method Percentage of participants reporting prompted systemic events within 7 days following investigational product administration Day 7 Percentage of participants reporting prompted local reactions within 7 days following investigational product administration Day 7 Percentage of participants reporting adverse events (AEs) through 1 month following investigational product administration 1 month Percentage of participants reporting serious adverse events (SAEs) through 6 months following investigational product administration 6 months
- Secondary Outcome Measures
Name Time Method GMTs before and through 1 month following investigational product administration Before vaccination through to 1 month after vaccination
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Trial Locations
- Locations (29)
Upstate Global Health Institute
🇺🇸East Syracuse, New York, United States
University of Rochester Medical Center
🇺🇸Rochester, New York, United States
AMR Clinical
🇺🇸Knoxville, Tennessee, United States
Diablo Clinical Research, Inc.
🇺🇸Walnut Creek, California, United States
DM Clinical Research - Philadelphia
🇺🇸Philadelphia, Pennsylvania, United States
DM Clinical Research- Cyfair
🇺🇸Houston, Texas, United States
SMS Clinical Research
🇺🇸Mesquite, Texas, United States
Clinical Research Consulting
🇺🇸Milford, Connecticut, United States
Clinical Research Professionals
🇺🇸Chesterfield, Missouri, United States
Clinical Research Associates Inc
🇺🇸Nashville, Tennessee, United States
Kaiser Permanente Washington Health Research Institute (KPWHRI)
🇺🇸Seattle, Washington, United States
Alliance for Multispecialty Research, LLC
🇺🇸Coral Gables, Florida, United States
Palm Springs Community Health Center
🇺🇸Miami Lakes, Florida, United States
J. Lewis Research, Inc. / Foothill Family Clinic South
🇺🇸Salt Lake City, Utah, United States
Anaheim Clinical Trials, LLC
🇺🇸Anaheim, California, United States
Orange County Research Center
🇺🇸Lake Forest, California, United States
Artemis Institute for Clinical Research
🇺🇸San Diego, California, United States
Miami Dade Medical Research Institute, LLC
🇺🇸Miami, Florida, United States
East-West Medical Research Institute
🇺🇸Honolulu, Hawaii, United States
Las Vegas Clinical Trials
🇺🇸North Las Vegas, Nevada, United States
Coastal Carolina Research Center
🇺🇸North Charleston, South Carolina, United States
Dynamed Clinical Research, LP d/b/a DM Clinical Research
🇺🇸Tomball, Texas, United States
Indago Research & Health Center, Inc
🇺🇸Hialeah, Florida, United States
Clinical Research Atlanta
🇺🇸Stockbridge, Georgia, United States
Trial Management Associates - Wilmington - Floral Parkway
🇺🇸Wilmington, North Carolina, United States
Centricity Research Columbus Ohio Multispecialty
🇺🇸Columbus, Ohio, United States
Headlands Horizons, LLC dba Headlands Research-Brownsville
🇺🇸Brownsville, Texas, United States
J. Lewis Research, Inc. / Foothill Family Clinic
🇺🇸Salt Lake City, Utah, United States
Charlottesville Medical Research
🇺🇸Charlottesville, Virginia, United States